We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc (FRX)

( 0.00% )
Updated: 10:30:34

Fennec Pharmaceuticals Inc Financial Summary

The current FRX market cap is 372.16M. The company's latest EPS is USD -0.5937 and P/E is -23.19.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0170k01.54M21.25M
Operating Income -13.01M-17.89M-17.22M-22.74M-12.77M
Net Income -12.78M-18.11M-17.35M-23.71M-16.05M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 14.15M31.42M22.41M26.94M26.86M
Total Liabilities 2.27M2.35M6.64M29.51M38.49M
Total Equity 11.88M29.07M15.77M-2.57M-11.62M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -9.06M-15.6M-14.22M-18.06M-17.14M
Investing N/A N/A N/A N/A N/A
Financing -71k32.29M4.98M20.73M6.64M
Market Cap 372.16M
Price to Earnings Ratio -23.19
Price to Sales Ratio 17.51
Price to Cash Ratio 28.04
Price to Book Ratio -32.02
Dividend Yield -

Share Statistics

Shares Outstanding 27.03M
Average Volume (1 week) 303
Average Volume (1 Month) 424
52 Week Change 30.27%
52 Week High 15.43
52 Week Low 9.27
Spread (Intraday) 0.18 (1.35%)

Company Info

Company Name Fennec Pharmaceuticals Inc
Address c/o labarge weinstein llp
ottawa, ontario K2K 3G4
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock